INVESTIGATIONS BOOTCAMP NIBRT (NATIONAL INSTITUTE FOR BIO-PROCESSING RESEARCH AND TRAINING)

Similar documents
Stability Studies for Pharmaceutical Products (API and finished products)

EFFECTIVE PROCESS VALIDATION NUSAGE PharmEng Pharmaceutical and Biotechnology Training Program Copyright 2014 NUSAGE-PharmEng.

An Introduction to Double Dragon Consulting

An Introduction to Double Dragon Consulting

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Margit Schwalbe-Fehl, Ph.D.

The long anticipated draft of the FDA s

TRAINING TITLE: Quality Risk Management Certification (CERT-004)

SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

SOPs for FDA-Regulated Industry Best Practices to Withstand FDA Expectations

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION

Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

EFFECTIVE CLINICAL TRIALS. NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program. Copyright 2014 NUSAGE-PharmEng.

Process Validation for Active Pharmaceutical Ingredients (API)

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Analytical Method Validation

Cleaning Validation in Active Pharmaceutical Ingredient Manufacturing Plants

Process Validation. Instructor Philip K. Ngai, Ph.D.* Senior Advisor & Trainer. National University of Singapore Academy of GxP Excellence (NUSAGE)

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program GMP FACILITY DESIGN WITH GOOD ENGINEERING PRACTICE

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program COMPUTERIZED SYSTEM VALIDATION

a n d B i o s a fety C o n s i d e ra t i o n s

Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)

Process Analytical Technology (PAT)

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)

Modern Validation Technology Boot Camp

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program FUNDAMENTALS OF MEDICAL DEVICE REGULATORY AFFAIRS

ICH Q 9 Training Course November 2015, Heidelberg, Germany. ICH Q 10 Training Course November 2015, Heidelberg, Germany ECA

Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA Zenaida Power Regulatory Expertise:

ICH Q9 Q uality R isk M anagement

GMP. Safeguard The Patient s Health.

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

TRAINING, AUDITING, INTERIM MANAGEMENT AND CONSULTANCY

ICH Q 10 Pharmaceutical Quality System

Curriculum Vitae. SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone:

Risk Based Incoming Quality Assurance (IQA)

Audit Trail Review for Computerised Systems in Analytical Laboratories

GMP In-house Training

Job Title: Head, Clinical Science Job Location: Nanjing, China CV to: Wechat:

Designing and Sustaining New and Existing Product Stability Testing Program

Root Cause Analysis and CAPA using 8-D Problem Solving Method

When the FDA comes knocking, will your inspection be a success? YES

Journal home page: RESEARCH ARTICLE

Risk Based Approach ISO 9001:2015 Internal Auditor Training

Executive Search. Chief Standards Officer

Cleaning-Disinfection-Sterilization of Reusable Medical Devices

Pharmaceutical Water System Sampling The Why s, Where s, and How s of Doing It Right

Speakers Title & Biography

Validation & Transfer of Methods for

Shop Floor Retail Bootcamp

Career in Biotechnology Industry. Novartis Biocamp Roadshow

QP s experience with QRM. Fergus O Connell QA Manager AMS Laboratories

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management

PDA Bioburden and Biofilm Workshop

MEDICAL DEVICE QUALITY & COMPLIANCE Institute 2013

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

When the FDA comes knocking, will your inspection be a success? YES

Cleaning Validation-Common Errors

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC)

Full IFRS vs. IFRS for SMEs seminar. AL Khobar, 7 May 2018

PMDA Perspective: Regulatory Updates on Process Validation Standard

Liquid Chromatography Boot Camp Plus For pharmaceutical and Biopharmaceutical industries

GxP Auditing, Remediation, and Quality System Resourcing

COMBINATION PRODUCTS Inspection Readiness and Outcomes

T H E P R O P O S A L F O R T H E Y E A R

Establishing the Self Inspections and Controls for Ensuring Audits to Confirm Effective Laboratory Data Integrity, Data Integrity Controls,

Job Openings at SoliPharma

James B. Powers, Jr. MSA, BS-BioChem Managing Partner, BAI

IGNITE LINE & MIDDLE MANAGEMENT DEVELOPMENT PROGRAMME IGNITE

Process Validation for FDA Regulated Industries

Packaging and Labeling in Pharmaceutical Production

Computerized System Validation Part of the Pharmaceutical and Biotechnology Training Courses

Seminar on Product Stability and Predictive Tools by GEA-NUS, Singapore & FreeThink, US

James B. Powers, Jr. MSA, BS-BioChem Partner. James Powers is a Quality, Compliance and Lean Leader with over 25 years of pharmaceutical experience.

Role of Industrial Engineer in Compliance with FDA Regulations

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

2018 SALARY GUIDE. Science & Pharma.

GxP Auditing, Remediation, and Staff Augmentation

EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT

CLOSING DATE: 27 TH SEPTEMBER 2013

GxP Auditing, Remediation, and Staff Augmentation

Setting Specifications and. Acceptance Criteria November 2015, Berlin, Germany ECA. Highlights:

ASCENDIA PHARMACEUTICALS Aspiring for Better Medicine

MBA Certification Programs

Laboratory Data Integrity Master Class

AGENDA. 12:00 p.m. 1:00 p.m. Registration 1:00 p.m. 4:00 p.m. Pre-Conference Workshop: Data Integrity Problems on the Rise

Self-Inspection and its potential benefits via ICH Q9 & Q10

Isolator Technology Workshop Engineering - Validation - Operation

EU GMP ANNEX 1 CHANGES CLARIFICATION AND IMPACT

Successful completion of the course will result in a certificate for 0.8 CEUs being issued. Auditing experience is not required for the class.

EU GMP ANNEX 1 DRAFT CLARIFICATION AND IMPACT

Basics of Drug Regulatory Affairs - SFDA & GCC Explained Date Of The Training

SFDA Pharmacovigilance System Explained

Transcription:

INVESTIGATIONS BOOTCAMP IN PARTNERSHIP WITH NIBRT (NATIONAL INSTITUTE FOR BIO-PROCESSING RESEARCH AND TRAINING) Dates: January 29 th - 31 st, 2013 Time: 8:30am-5:30pm Venue: NIBRT, Dublin

Training Outline Day One "Investigations An IMB Perspective" Dr Kevin O Donnell, Market Compliance Manager, Irish Medicines Board Human Factors in the Management of Investigations: Dr Ginette M. Collazo Definition Human Errors Human behaviour How are we? Why do humans make mistakes? The systems: The conditions Root cause categories in human error investigations System Errors (that cause human errors) Human Error: o Procedures o Human Error Engineering o Training o Direct Supervision o Communication o Related to the individual (performance) Determine Root Cause The five - Why? Validation of Root Cause Prediction and Prevention Human Factor Concept Practice Days Two & Three Investigations in the Life Sciences sectors: Victor Sanchez and Magaly Aham What is an Investigation? Regulatory Requirements for Investigations Regulatory Citations linked to investigations Types of investigations (Manufacturing, Laboratory, Complaints, Exception Deviations) Elements of an investigation o Problem Statement o Scope o Risk assessment and impact analysis Presentation of tools o Trend analysis o Root Cause Analysis Root Cause Methodologies o CAPA o Effectiveness Checks Documenting Investigations

o o o Investigation Report Purpose and regulatory expectations Investigation Design Writing for your audience Executive Summary Supporting Documentation Monitoring the Quality System State Tracking and trending investigations Monitoring effectiveness checks Who should Attend this event Bio-Pharma & Medtech Project Managers/Leaders QA/QC Manufacturing Personnel Technical Services Planning/Procurement Supervisors/Managers Validation Engineering Information Technology Management Speaker Profile Dr Kevin O Donnell, Market Compliance Manager, Irish Medicines Board Kevin O Donnell, Ph.D., is Market Compliance Manager at the Irish Medicines Board (IMB) in Dublin, Ireland. He is responsible for a number of compliance-related and market-surveillance programs at IMB, such as the quality defect and recall program and the sampling and analysis market surveillance activities. Kevin is active at a European level in various regulatory activities and initiatives. He represents Ireland at the European Directorate for the Quality of Medicines in Strasbourg, France, in support of IMB s market surveillance testing activities. In 2007, he was elected to the Advisory Group for the General Official Medicines Control Laboratory Network and is also a member of the PIC/S Expert Circle on Quality Risk Management. Kevin worked in the pharmaceutical industry both in Ireland and in the United States before joining the IMB. Kevin obtained his chemistry degree from the University College Galway and both Masters and Ph.D. degrees from the Dublin Institute of Technology. His Ph.D. research related to the development of a practical quality risk management solution designed for use within good manufacturing practice (GMP)-related environments as an aid in facilitating compliance with the risk-based qualification, validation, and change control environments of the European Union (EU). That work resulted in several peer-reviewed research papers, one of which was awarded the Article of the Year award by the Journal of Validation Technology in 2007.

Resources Dr. Ginette M. Collazo has vast knowledge of GMP regulations and has worked in organizational reengineering and change management through the implementation of Strategies of Collective Behaviour Modification resulting in increased productivity. Ginette has specialized studies in Human Reliability and "The human factor in processes, human reliability and error prevention." She has been a speaker at: Interphex, American Institute for Chemical Engineers (AIChE), PR Psychologist Association, American Society for Quality (ASQ) and the Food and Drug Administration (FDA). Víctor Sánchez, a Summa Cum Laude Chemist, holds an MBA in Industrial Management from the InterAmerican University of Puerto Rico and is an MS candidate in Pharmaceutical Validation Technology from the Dublin Institute of Technology, Ireland. Victor is the President of European Operations for Pharma-Bio Serv LTD, a consulting service company which provides on-site support and training to FDA and EMA/EU regulated industries. Mr. Sánchez's expertise focuses in the areas of: manufacturing and quality operations, analytical method development and validation, analytical problem solving, process validation, GMP quality systems, and regulatory compliance. Prior to joining Pharma-Bio Serv in 2011, Victor spent seventeen (17) years in senior positions in quality and manufacturing operations, both in PR and Spain, directing efforts to roll over quality improvement and operational excellence programs. Víctor, based in Spain, teaches compliance disciplines, such as cleaning validation and QbD, in a Pharmaceutical Industry Master's Program from a recognized Spanish institution. He also trains groups in technical writing and root cause analysis. He is a PDA and ISPE active member. Magaly Aham has comprehensive management experience in Quality Assurance, Quality Systems, Compliance, Quality Control, Validation and Manufacturing Operations. She holds an outstanding career track record of improving compliance, quality, efficiency, efficacy and maximization of manpower through continuous process improvement. Magaly is the Director of Compliance and US Operations of Pharma-Bio Serv US. Her previous roles include Senior Manager Quality Systems, at MedImmune, Inc., Corporate Headquarters, MD; QC Associate Director at Wyeth Pharmaceuticals, PR; Manufacturing Operations Technical Assistance Manager at Schering, PR where she was appointed as API Consent Decree Leader with accomplishments including closing all API Consent Decree commitments a month before due date, exceeding the exceptional rating selected by the facility. At Schering she also held roles that included: Kepner-Tregoe Consent Decree Problem Analysis Leader, Change Control Manager, Regulatory Compliance Product Quality Revalidation Supervisor, Manufacturing Operations Process Support Specialist and Quality Assurance Specialist. Magaly holds a BS in Chemistry from the University of Puerto Rico and an MS in Bioscience and Regulatory Affairs from The Johns Hopkins University (to be completed 2012). Magaly is Kepner- Tregoe PSDM Certified, a Certified Trainer, ASQ Certified Quality Auditor (CQA) and a Licensed Chemist. She is a PDA active member.

Costs 1790 (+VAT) to include refreshments and lunch on 3 days 1590 (+VAT) for second and subsequent attendees Early Bird 1590 (+VAT) if confirmed by December 21 st 2012 Booking/Further Information Email rscanlan@pharmabioserv.com Phone 353 21 461 9034 www.nibrt.ie/trainingforindustry Payment Options Bank Transfer Cheque